Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
28.09
+1.22 (4.54%)
At close: Apr 17, 2026, 4:00 PM EDT
27.98
-0.11 (-0.37%)
After-hours: Apr 17, 2026, 5:48 PM EDT
Maze Therapeutics Employees
Maze Therapeutics had 141 employees as of December 31, 2025. The number of employees increased by 16 or 12.80% compared to the previous year.
Employees
141
Change (1Y)
16
Growth (1Y)
12.80%
Revenue / Employee
n/a
Profits / Employee
-$929,929
Market Cap
1.40B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 141 | 16 | 12.80% |
| Dec 31, 2024 | 125 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immatics | 711 |
| Wave Life Sciences | 317 |
| Precigen | 160 |
| MapLight Therapeutics | 133 |
| Olema Pharmaceuticals | 131 |
| MoonLake Immunotherapeutics | 130 |
| AtaiBeckley | 99 |
MAZE News
- 24 days ago - MAZE Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 25 days ago - Maze Therapeutics Stock Falls Despite Strong Phase 2 Kidney Drug Data For MZE829 - Benzinga
- 25 days ago - Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease - GlobeNewsWire
- 25 days ago - Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights - GlobeNewsWire
- 7 weeks ago - Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 3 months ago - Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights - GlobeNewsWire